Pediatric Research, Journal Year: 2018, Volume and Issue: 85(2), P. 155 - 165
Published: Nov. 16, 2018
Language: Английский
Pediatric Research, Journal Year: 2018, Volume and Issue: 85(2), P. 155 - 165
Published: Nov. 16, 2018
Language: Английский
Seminars in Cell and Developmental Biology, Journal Year: 2020, Volume and Issue: 112, P. 123 - 136
Published: Aug. 6, 2020
Language: Английский
Citations
80Neurobiology of Disease, Journal Year: 2021, Volume and Issue: 163, P. 105607 - 105607
Published: Dec. 31, 2021
Brain disorders are characterized by the progressive loss of structure and function brain as a consequence degeneration and/or death nerve cells. Aging is major risk factor for such Alzheimer's disease (AD), Parkinson's (PD), amyotrophic lateral sclerosis (ALS), stroke. Various cellular molecular events have been shown to play role in progress neurodegenerative diseases. Emerging studies suggest that primary cilia could be key regulator The cilium singular organelle expressed on surface many cell types, astrocytes neurons mature brain. Primary detect extracellular cues, Sonic Hedgehog (SHH) protein, transduce these signals into cells regulate various signaling pathways. Abnormalities ciliary length frequency (ratio ciliated cells) implicated human diseases, including disorders. This review summarizes current findings thoughts pathways aging age-related
Language: Английский
Citations
80Neurogastroenterology & Motility, Journal Year: 2019, Volume and Issue: 32(1)
Published: Oct. 2, 2019
Abstract Background A hallmark feature of Parkinson's disease (PD) is the build‐up α‐synuclein protein aggregates throughout brain; however also expressed in enteric neurons. Gastrointestinal (GI) symptoms and pathology are frequently reported PD, including constipation, increased intestinal permeability, glial pathology, alterations to gut microbiota composition. can propagate through neuronal systems but site origin whether it be or brain, still unknown. Physical exercise associated with alleviating PD altering composition microbiota. Methods This study investigated effects bilateral nigral injection adeno‐associated virus (AAV)‐α‐synuclein on neurons, glia neurochemistry, microbiome, bile acid metabolism rats, some whom were exposed voluntary exercise. Key Results Nigral overexpression resulted significant loss ileal submucosal plexus no change glia. In contrast, myenteric showed a increase expression, while numbers maintained. Concomitant observed microbiome related metabolism. Voluntary running protected against loss, modified brain‐injected AAV‐α‐synuclein model. Conclusions Inferences These results show that developing this model exerts nervous system (ENS) receptive modification by highlights brain communication as an important mechanism pathology.
Language: Английский
Citations
78Neurochemistry International, Journal Year: 2021, Volume and Issue: 145, P. 105014 - 105014
Published: March 8, 2021
Language: Английский
Citations
67Neurotoxicity Research, Journal Year: 2022, Volume and Issue: 40(1), P. 319 - 345
Published: Jan. 11, 2022
Language: Английский
Citations
50Neurochemistry International, Journal Year: 2022, Volume and Issue: 158, P. 105376 - 105376
Published: June 3, 2022
Language: Английский
Citations
41Life Sciences, Journal Year: 2023, Volume and Issue: 337, P. 122356 - 122356
Published: Dec. 18, 2023
Metabolic syndrome (MetS), which is characterized by insulin resistance, high blood glucose, obesity, and dyslipidemia, known to increase the risk of dementia accompanied memory loss depression. The direct pathways specific mechanisms in central nervous system (CNS) for addressing fatty acid imbalances MetS have not yet been fully elucidated. Among polyunsaturated acids, linoleic (LA, n6-PUFA) α-linolenic (ALA, n3-PUFA), are two essential acids that should be provided food sources (e.g., vegetable oils seeds), reported regulate various cellular including apoptosis, inflammatory responses, mitochondrial biogenesis, signaling. Furthermore, inadequate intake LA ALA involved neuropathology neuropsychiatric diseases as well imbalanced metabolic conditions. Herein, we review roles on metabolic-related focusing synaptic plasticity, cognitive function, issues. This suggests important concurrent treatment both neurological problems.
Language: Английский
Citations
30Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 85, P. 101838 - 101838
Published: Jan. 5, 2023
Language: Английский
Citations
27Frontiers in Aging Neuroscience, Journal Year: 2023, Volume and Issue: 15
Published: Sept. 5, 2023
Parkinson's disease (PD) is the second-most common neurodegenerative and largely caused by death of dopaminergic (DA) cells. Dopamine loss occurs in substantia nigra pars compacta leads to dysfunctions motor functions. Death DA cells can occur with oxidative stress dysfunction glial Parkinson-related gene mutations. Lactoferrin (Lf) a multifunctional glycoprotein that usually known for its presence milk, but recent research shows Lf also found brain regions. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mitochondrial toxin disturbs electron transport chain (ETC) system increases rate reactive oxygen species. Lf's high affinity metals decreases required iron Fenton reaction, reduces damage MPTP, their surveillance rate. Several studies investigated effect on neurons are treated MPTP. The results pointed out protective be observed without stress; thus, several potential mechanisms currently being researched, starting HSPG–Lf interaction cellular membrane activity region showed lactoferrin initiates receptor-mediated transcytosis blood–brain barrier (BBB) existence receptors endothelial both created idea using as secondary molecule therapeutic agents across BBB, especially nanoparticle development.
Language: Английский
Citations
26International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(19), P. 14582 - 14582
Published: Sept. 26, 2023
Parkinson’s disease is a neurodegenerative exhibiting the fastest growth in incidence recent years. As with most diseases, pathophysiology incompletely elucidated, but compelling evidence implicates inflammation, both central nervous system and periphery, initiation progression of disease, although it not yet clear what triggers this inflammatory response where begins. Gut dysbiosis seems to be likely candidate for systemic inflammation. The therapies current use provide only symptomatic relief, do interfere progression. Nonetheless, animal models have shown promising results that target various vicious neuroinflammatory cascades. Translating these therapeutic strategies into clinical trials still its infancy, series issues, such as exact timing, identifying biomarkers able identify early pre-symptomatic stages, or proper indications genetic testing population at large, will need settled future guidelines.
Language: Английский
Citations
24